Bacillus coagulans TL3 Inhibits LPS-Induced Caecum Damage in Rat by Regulating the TLR4/MyD88/NF-κB and Nrf2 Signal Pathways and Modulating Intestinal Microflora
- 2022-02-07
- Oxidative Medicine and Cellular Longevity 2022
- Yan Wang
- Jianxin Lin
- Ziyang Cheng
- Tiancheng Wang
- Jia Chen
- M. Long
- PubMed: 35178157
- DOI: 10.1155/2022/5463290
Abstract
Background: Bacillus coagulans has been widely used in food and feed additives, which can effectively inhibit the growth of harmful bacteria, improve intestinal microecological environment, promote intestinal development, and enhance intestinal function, but its probiotic mechanism is not completely clear.
Aim: The aim of this study is to discuss the effect and mechanism of Bacillus coagulans TL3 on oxidative stress and inflammatory injury of cecum induced by LPS.
Method: The Wistar rats were randomly divided into four groups, each containing 7 animals. Two groups were fed with basic diet (the LPS and control, or CON, groups). The remaining groups were fed with basic diet and either a intragastric administration high or low dose of B. coagulans, forming the HBC and LBC groups, respectively. The rats were fed normally for two weeks. On the 15th day, those in the LPS, HBC, and LBC groups were injected intraperitoneally with LPS-the rats in the CON group were injected intraperitoneally with physiological saline. After 4 hours, all the rats were anesthetized and sacrificed by cervical dislocation, allowing samples to be collected and labeled. The inflammatory and antioxidant cytokine changes of the cecum were measured, and the pathological changes of the cecum were observed, determining the cecal antioxidant, inflammation, and changes in tight junction proteins and analysis of intestinal flora.
Result: The results show that LPS induces oxidative damage in the cecal tissues of rats and the occurrence of inflammation could also be detected in the serum. The Western blot results detected changes in the NF-κ_B- and Nrf2-related signaling pathways and TJ-related protein levels. Compared with the LPS group, the HBC group showed significantly downregulated levels of expression of Nrf2, NQO1, HO-1, GPX, and GCLC. The expression of TLR4, MYD88, NF-κ_B, IL-6, TNF_α, and IL-1_β was also significantly downregulated, while the expression of other proteins (ZO-1, occludin, and claudin-1) increased significantly. Bacillus coagulans TL3 was also found to increase the relative abundance of the beneficial bacterium Akkermansia muciniphila in the intestines. There is also a significant reduction in the number of harmful bacteria Escherichia coli and Shigella (Enterobacteriaceae).
Conclusion: Bacillus coagulans TL3 regulates the TLR4/MyD88/NF-_κ_B and Nrf2 signaling pathways in the cecal tissue of rats, protects the intestine from inflammation and oxidative damage caused by LPS, and inhibits the reproduction of harmful bacteria and promotes beneficial effects by regulating the intestinal flora bacteria grow, thereby enhancing intestinal immunity.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus coagulans | Altered Gut Microbiota | Beneficial | Moderate |
Bacillus coagulans | Improved Intestinal Barrier Function | Beneficial | Large |
Bacillus coagulans | Reduced Inflammation Levels | Beneficial | Large |
Bacillus coagulans | Reduced Oxidative Damage | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Improved Beneficial Intestinal Bacteria | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Improved Intestinal Barrier Function | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Reduced Harmful Intestinal Bacteria | Beneficial | Large |
Bacillus coagulans MTCC 5856 | Reduced Oxidative Damage in Cecal Tissues | Beneficial | Large |
Bacillus coagulans ProDura | Improved Gut Microflora | Beneficial | Moderate |
Bacillus coagulans ProDura | Improved Tight Junction Protein Expression | Beneficial | Moderate |
Bacillus coagulans ProDura | Reduced Harmful Gut Bacteria | Beneficial | Large |
Bacillus coagulans ProDura | Reduced Inflammatory Response | Beneficial | Large |
Bacillus coagulans ProDura | Reduced Oxidative Damage in Cecal Tissues | Beneficial | Large |
Bacillus coagulans SC208 | Enhanced Intestinal Immunity | Beneficial | Moderate |
Bacillus coagulans SC208 | Improved Abundance of Beneficial Bacteria | Beneficial | Moderate |
Bacillus coagulans SC208 | Improved Intestinal Barrier Function | Beneficial | Large |
Bacillus coagulans SC208 | Reduced Bacterial Levels | Beneficial | Moderate |
Bacillus coagulans SC208 | Reduced Inflammation Levels | Beneficial | Large |
Bacillus coagulans SC208 | Reduced Oxidative Damage | Beneficial | Large |
Bacillus coagulans SNZ-1969 | Enhanced Gut Flora Composition | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Improved Intestinal Barrier Integrity | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Reduced Harmful Gut Microbiota | Beneficial | Moderate |
Bacillus coagulans SNZ-1969 | Reduced Intestinal Inflammation | Beneficial | Large |
Bacillus coagulans SNZ-1969 | Reduced Oxidative Damage in Intestinal Tissue | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Enhanced Intestinal Immunity | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Improved Gut Microbiome Composition | Beneficial | Moderate |
Bacillus coagulans Unique IS-2 | Improved Intestinal Barrier Function | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Reduced Harmful Bacteria | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Reduced Hepatic Oxidative Stress | Beneficial | Large |
Bacillus coagulans Unique IS-2 | Reduced Inflammation Levels | Beneficial | Large |